Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Implant,Ti,3.75X13: medical device reports filed with FDA

4,433 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

4,433
device reports naming the brand
0% of all MAUDE reports · about 657 a year
1,823
reports, 12 months to August 2026
1,067 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,433 reports that name the brand "GM Helix Implant,Ti,3.75X13" (endosseous dental implant), received between October 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

1,823 reports arrived in the 12 months to August 2026, up 71% from 1,067 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (83.2%), loss of osseointegration (10.7%) and difficult to insert (0.8%). The patient problems coded most often are pain, fibrosis and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0132264Sep 2021: 7Oct 2021: 6Nov 2021: 22Dec 2021: 132022Jan 2022: 15Feb 2022: 14Mar 2022: 36Apr 2022: 36May 2022: 37Jun 2022: 21Jul 2022: 34Aug 2022: 30Sep 2022: 30Oct 2022: 36Nov 2022: 18Dec 2022: 322023Jan 2023: 27Feb 2023: 34Mar 2023: 35Apr 2023: 42May 2023: 44Jun 2023: 45Jul 2023: 44Aug 2023: 42Sep 2023: 46Oct 2023: 43Nov 2023: 54Dec 2023: 382024Jan 2024: 36Feb 2024: 56Mar 2024: 54Apr 2024: 75May 2024: 79Jun 2024: 71Jul 2024: 71Aug 2024: 100Sep 2024: 64Oct 2024: 91Nov 2024: 95Dec 2024: 1092025Jan 2025: 73Feb 2025: 67Mar 2025: 81Apr 2025: 53May 2025: 0Jun 2025: 232Jul 2025: 85Aug 2025: 117Sep 2025: 92Oct 2025: 130Nov 2025: 133Dec 2025: 2642026Jan 2026: 117Feb 2026: 133Mar 2026: 147Apr 2026: 136May 2026: 175Jun 2026: 168Jul 2026: 139Aug 2026: 189

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

06641,3272019: 320192020: 4820202021: 11720212022: 33920222023: 49420232024: 90120242025: 1,32720252026: 1,2042026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,433
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report91.3%4,049
Voluntary report0%0
User facility report0%0
Distributor report8.7%384
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,69083.2%62.8%
Loss of osseointegration47410.7%22.4%
Difficult to insertthe device was hard to insert360.8%0.4%
Fracturea broken bone210.5%1.6%
Separation failure110.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified86919.6%
Fibrosis86419.5%
Inflammationinflammation2635.9%
Fistula1764%
Swelling/ edema1593.6%
Hemorrhage/blood loss/bleeding1553.5%
Abscessa collection of pus751.7%
Hyperresponsive to stimuli521.2%
Hypersensitivity/allergic reaction290.7%
Numbnessnumbness140.3%
Tissue damage130.3%
Failure of implant50.1%
Sinus perforation40.1%
Inadequate osseointegration20%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Implant,Ti,3.75X13Product code DZEAll MAUDE reports
Reports4,4333,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer91.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Implant,Ti,3.75X13 reports

How many FDA reports name GM Helix Implant,Ti,3.75X13?

4,433 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,823 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (83.2%), loss of osseointegration (10.7%), difficult to insert (0.8%), fracture (0.5%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (91.3%) and distributor reports (8.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Implant,Ti,3.75X13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.